How is rhabdomyolysis diagnosed in a patient with acute muscle pain, swelling, weakness, dark‑colored urine and recent intense exercise, trauma, immobilization, seizures, or drug exposure?

Diagnosis of Rhabdomyolysis

Diagnose rhabdomyolysis by measuring serum creatine kinase (CK), which is the biochemical gold standard—a level ≥5 times the upper limit of normal (or ≥1,000 IU/L) in the appropriate clinical context confirms the diagnosis. 1, 2

Clinical Presentation

The diagnosis begins with recognizing the clinical syndrome, though the classic triad is often absent:

• Muscle pain (myalgia), weakness, and dark-colored urine constitute the classic triad, but this appears in less than 10% of patients—do not wait for all three features to be present. 3, 4
• Dark or tea-colored urine suggests myoglobinuria and indicates significant muscle breakdown. 2, 5
• Muscle swelling, tenderness, or stiffness may be present, particularly in traumatic or exertional cases. 1, 4
• Many patients present with nonspecific symptoms or are entirely asymptomatic except for laboratory abnormalities. 3

Essential Laboratory Tests

Primary Diagnostic Test

• Serum creatine kinase (CK) is the diagnostic gold standard—levels typically exceed 5 times the upper limit of normal (often >1,000 IU/L), and may reach 100,000 IU/L or higher in severe cases. 1, 2, 3
• CK levels peak 24–120 hours after the inciting event, so a single normal value does not exclude rhabdomyolysis if obtained early—repeat measurement at 24 hours if clinical suspicion remains high. 1
• Use total CK, not CK-MB, as CK-MB lacks sensitivity and specificity for rhabdomyolysis and is designed for cardiac injury assessment. 1

Prognostic and Confirmatory Tests

• Urine myoglobin is the gold standard for prognosis, particularly in non-traumatic rhabdomyolysis, though it has a shorter half-life than CK. 6, 2
• Urinalysis showing positive blood without red blood cells (dipstick positive for blood but microscopy negative for RBCs) indicates myoglobinuria and strongly supports the diagnosis. 1
• Serum myoglobin can be detected earlier than CK but is rapidly cleared, making it less reliable if measured late. 6

Essential Monitoring Tests

• Complete electrolyte panel to assess for hyperkalemia (life-threatening), hypocalcemia, and hyperphosphatemia—hyperkalemia is the most urgent complication requiring immediate treatment. 1, 6
• Serum creatinine and BUN to monitor for acute kidney injury, which develops in 13–50% of patients and is the most serious complication. 6, 2
• Serum potassium requires close monitoring as hyperkalemia can precipitate fatal cardiac arrhythmias. 7, 1

Additional Muscle Enzymes

• LDH, AST (SGOT), ALT (SGPT), and aldolase are commonly elevated and support the diagnosis, though they are less specific than CK. 1

Severity Stratification

• CK >5,000 IU/L indicates severe rhabdomyolysis requiring intensive monitoring and aggressive fluid resuscitation. 1, 6
• CK >15,000–16,000 IU/L is associated with high risk of acute kidney injury and potential need for renal replacement therapy. 1, 3
• CK >75,000 IU/L (particularly in crush injury) carries >80% risk of acute kidney injury. 6

Etiology-Specific Investigations

Once rhabdomyolysis is confirmed, identify the underlying cause:

• Medication review: Document all prescription drugs (especially statins), over-the-counter medications, herbal supplements, and performance-enhancing products. 1
• Toxicology screen: Ask about recreational drug use (cocaine, methamphetamine, MDMA, ketamine, heroin) as these are common causes. 1
• Viral studies if viral myositis is suspected. 1, 6
• Autoimmune markers (ANA, ASMA, ANCA) if autoimmune myositis is suspected. 1, 6
• Thyroid function tests as hypothyroidism predisposes to statin-induced rhabdomyolysis. 1

Recurrent or Unexplained Rhabdomyolysis

For patients with recurrent episodes, exercise intolerance, or family history of neuromuscular disorders:

• Genetic testing for metabolic myopathies: CPT2, PYGM, ACADM, AMPD1, VLCAD gene testing. 1
• Malignant hyperthermia susceptibility testing: RYR1 and CACNA1S gene sequencing, particularly in exertional rhabdomyolysis or heat illness. 1, 6
• EMG and MRI may help differentiate inflammatory myositis from rhabdomyolysis. 6

Monitoring During Treatment

• Serial CK measurements every 6–12 hours initially in severe cases (CK >5,000 IU/L) until levels decline, then daily. 1, 6
• Electrolytes, creatinine, and potassium every 6–12 hours until CK is declining and renal function is stable. 1, 6
• Urine output monitoring via bladder catheter to ensure adequate diuresis (target ≥300 mL/hour or 2 mL/kg/hour). 1, 8
• ECG monitoring to detect cardiac arrhythmias from hyperkalemia. 6

Compartment Syndrome Assessment

In traumatic cases, assess for compartment syndrome, which can both cause and complicate rhabdomyolysis:

• Early signs: Pain, tension, paresthesia, and paresis—these require immediate action. 1, 6
• Late signs: Pulselessness and pallor indicate irreversible damage. 1
• Compartment pressure measurement: Fasciotomy is indicated when pressure exceeds 30 mmHg or when differential pressure (diastolic BP – compartment pressure) is <30 mmHg. 1

Common Diagnostic Pitfalls

• Do not rely on the classic triad—most patients do not present with all three features. 3
• Do not use a single early CK measurement to exclude rhabdomyolysis—CK peaks 24–120 hours after injury. 1
• Impact trauma can elevate CK without true rhabdomyolysis, but given clinical context (acute muscle pain, dark urine, recent intense exercise/trauma), assume true muscle breakdown until proven otherwise. 1
• Do not use CK-MB for diagnosis—it is designed for cardiac injury and lacks sensitivity for rhabdomyolysis. 1
• Do not overlook medication-induced causes—statins, fibrates (especially gemfibrozil), and drug interactions are common culprits. 1